Charles Elliott Sigal stock trades
Director at Vir Biotechnology and Alnylam Pharmaceuticals
No open-market buys or sales reported in the last 12 months. Their newest Form 4, for May 27: stock award (8,000 VIR shares).
The 2 companies Charles Elliott Sigal files at
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 0 | ||
| 0 |
Charles Elliott Sigal's trades, as filed
None on the open market in the last 12 months.
2 other filings on record (stock awards). Pro members see every filing and the shares Charles Elliott Sigal holds.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at their companies
- Marianne De Backer
- Jason O'Byrne
- Brent Sabatini
- Vanina de Verneuil
- Mark Eisner
- Vicki L. Sato
- Janet Napolitano
- Ramy Farid
- Robert J. More
- Timothy Coughlin
- Jeffrey S. Hatfield
- Norbert W. Bischofberger
- Yvonne Greenstreet
- Jeffrey V. Poulton
- Tolga Tanguler
- Pushkal Garg
- Kevin Joseph Fitzgerald
- Melissa McLaughlin
- Bryan Supran
- David E. I. Pyott
- Amy W. Schulman
- Colleen F. Reitan
- Dennis A. Ausiello
- Margaret A. Hamburg
- Olivier Brandicourt
- Peter N. Kellogg
- Stuart A. Arbuckle